ストックスクリーナーアプリを入手
58.62
1.43%
-0.85
アフターアワーズ：
58.72
0.10
+0.17%
Bristol Myers Squibb Co (BMY) 最新ニュース
Which Dividend Pharma Stock Should a Value Investor Choose Today? - The Motley Fool
Bartlett & CO. Wealth Management LLC Has $7.26 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView — Track All Markets
Assessing Bristol Myers Squibb (BMY) Valuation After Camzyos Data And T Cell Engager Collaboration News - Yahoo Finance
BMS and Oxford BioTherapeutics join forces in TCE discovery pact - Pharmaceutical Technology
Bristol Myers Squibb stock (US1101221083): Is its oncology pipeline strong enough to unlock new upsi - AD HOC NEWS
Bristol Myers Squibb Cancer Alliance Adds Weight To Valuation Debate - Yahoo Finance
F&V Capital Management, LLC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Janux secures $35 million milestone payment from Bristol Myers Squibb - MSN
Bristol-Myers Squibb Company (BMY) stock price, news, quote and history - Yahoo Finance Singapore
Bristol-Myers Likely to Get Desired Court in Paxton Plavix Suit - Bloomberg Law News
Oxford BioTherapeutics Partners with Bristol Myers Squibb for Next-Gen T-Cell Therapies - National Today
Bristol-Myers Squibb Earnings Preview: What to Expect - Yahoo Finance
Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours - Yahoo Finance
Cantor Fitzgerald Lifts Bristol Myers (BMY) Price Target but Flags Weak Q1 Catalyst - Insider Monkey
MFS Blended Research Core Equity Portfolio's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts - Yahoo Finance
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
MapLight's Psychosis Drug Could Deliver Billion-Dollar Upside, Says Analyst - Benzinga
Bristol-Myers Squibb: Vestmo Stock of the Week - Barron's
Cantor Fitzgerald raises Bristol-Myers Squibb stock price target to $54 - Investing.com
Guggenheim reiterates Bristol-Myers Squibb stock rating at Buy - Investing.com
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline - Reuters
Bristol-Myers Squibb Company (BRM.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
BMY Stock Price, Quote & Chart | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill
Bristol-Myers Squibb Company (BMY) latest stock news and headlines - Yahoo Finance UK
Bristol-Myers Squibb Company (BMY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Scotiabank Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $60 - 富途牛牛
Pleural Diseases Market Set to Boom Rapidly by 2033 |Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc - openpr.com
Nathan Pennell: "Global and Local" Model Takes Focus During BMS Japan Visit - Oncodaily
Case-By-Case Guide As Justices Eye Landmark Pharma Law - Law360
Trust Co. of Toledo NA OH Sells 55,523 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Element Squared LLC Acquires Shares of 48,420 Bristol Myers Squibb Company $BMY - MarketBeat
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock - Investing.com Australia
Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case - Yahoo Finance UK
BRISTOL-MYERS SQUIBB CO (BMYS.VI) Q1 FY2025 earnings call transcript - Yahoo Finance
Growth and Income Portfolio's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol-Myers Squibb Company (BMY) Options Chain - Yahoo! Finance Canada
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term - Yahoo Finance
BRISTOL-MYERS SQUIBB CO (BMYS.VI) Q2 FY2025 earnings call transcript - Yahoo Finance
Elkins, Bristol Myers Squibb CFO, sells $1.85 million in BMY stock By Investing.com - Investing.com South Africa
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co (BMY) Shares Down 3.58% on Apr 2 - GuruFocus
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review - Ad Age
Bristol Myers Squibb Cancer Pact And Equity Push Raise Valuation Questions - simplywall.st
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.58% on Apr 2: What Signal Does It Send? - TradingKey
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos - Insider Monkey
Ritter Alpha, LP's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Tema Etfs LLC Has $6.89 Million Holdings in Bristol Myers Squibb Company $BMY - marketbeat.com
20,914 Shares in Bristol Myers Squibb Company $BMY Acquired by J. Safra Sarasin Holding AG - MarketBeat
F&V Capital Management LLC Boosts Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
1.10%
0.21%
大文字化:
|
ボリューム (24 時間):